Table 4.
Relative change in the mean Hb concentration between baseline and day of follow up
| Relative median change in Hb from baseline | All | P. falciparum | All | P. vivax | ||||
|---|---|---|---|---|---|---|---|---|
| Pf-noPQ | Pf-PQ1 | p | Pv-noPQ | Pv-PQ14 | p | |||
| D1 (IQR, n) |
− 2.7% (− 9.09 to 1.92, 174) |
− 3.8% (− 7.75 to 2.27, 86) |
− 2.42% (− 9.33 to 0.00, 88) |
0.8161 | 0.0% (− 5.30 to 0.92, 62) |
0.0% (− 4.72 to 0.00, 30) |
0.0% (− 5.68 to 8.71, 30 |
0.219 |
| D2 (IQR, n) |
− 4.9% (− 10.62 to − 0.87, 163) |
− 4.4% (− 9.05 to 0.43, 72) |
− 5.6% (− 11.9 to 2.65, 91) |
0.525 | 0.0% (− 7.14 to 7.69, 61) |
0.0% (− 7.14 to 1.63, 32) |
0.0% (− 7.69 to 9.09, 29) |
0.460 |
| D7 (IQR, n) |
11.2% (0.00 to 19.54, 164) |
6.0% (− 0.76 to 14.81, 62) |
13.2% (0.00 to 23.89, 102) |
0.007 | 8.0% (0.00 to 15.38, 56) |
0.0% (0.00 to 10.00, 25) |
9.1% (0.00 to 15.38, 31) |
0.106 |
| D14 (IQR, n) |
16.5% (4.27 to 27.08, 162) |
13.3% (0.00 to 22.69, 57) |
18.6% (7.69 to 30.08, 105) |
0.006 | NA | 9.1% (NA, 1) |
n = 0 | NA |
| D16 (IQR, n) |
n = 0 | n = 0 | n = 0 | NA | 7.7% (0.00 to 18.18, 67) |
7.7% (0.00 to 18.18, 30) |
7.7% (0.00 to 18.18, 37) |
1.000 |
| D21 (IQR, n) |
15.4% (0.85 to 23.08, 147) |
15.0% (0.00 to 26.85, 61) |
15.4% (4.07 to 22.76, 86) |
0.939 | 8.3% (0.00 to 18.18, 55) |
7.7% (0.00 to 18.18, 23) |
8.7% (0.00 to 18.18, 32) |
0.614 |
| D28 (IQR, n) |
16.9% (4.41 to 26.46, 140) |
13.5% (0.83 to 24.77, 62) |
17.7% (6.40 to 28.46, 78) |
0.284 | 11.1% (0.00 to 21.10, 47) |
10.0% (0.00 to 18.18, 21) |
12.5% (0.00 to 21.10, 26) |
0.754 |
Significant values are in italics (p < 0.05)